BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 21498927)

  • 21. Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western Sardinia.
    Loviselli A; Oppo A; Velluzzi F; Atzeni F; Mastinu GL; Farci P; Orgiana G; Balestrieri A; Cocco PL; Mariotti S
    J Endocrinol Invest; 1999 Oct; 22(9):660-5. PubMed ID: 10595828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10.
    Zhang RW; Shao CP; Huo N; Li MR; Xi HL; Yu M; Xu XY
    World J Gastroenterol; 2015 Sep; 21(33):9765-73. PubMed ID: 26361424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of non-alcoholic fatty liver disease with thyroid peroxidase and thyroglobulin antibody: A new insight from SPECT-China study.
    Chen Y; Wang N; Chen Y; Li Q; Han B; Chen C; Zhai H; Lu Y
    Autoimmunity; 2018 Aug; 51(5):238-244. PubMed ID: 30016121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different Thyroidal Responses to Human Chorionic Gonadotropin Under Different Thyroid Peroxidase Antibody and/or Thyroglobulin Antibody Positivity Conditions During the First Half of Pregnancy.
    Hou Y; Liu A; Li J; Wang H; Yang Y; Li Y; Fan C; Zhang H; Wang H; Ding S; Teng W; Shan Z
    Thyroid; 2019 Apr; 29(4):577-585. PubMed ID: 30808250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of thyroid autoantibodies in hepatitis C and hepatitis B infection in China.
    Yang R; Shan Z; Li Y; Fan C; Li C; Teng W
    Intern Med; 2011; 50(8):811-5. PubMed ID: 21498927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid Disturbance in Patients with Chronic Hepatitis C Infection: A Systematic Review and Meta-analysis.
    Shen Y; Wang XL; Xie JP; Shao JG; Lu YH; Zhang S; Qin G
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):227-34. PubMed ID: 27308655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies?
    McLachlan SM; Rapoport B
    Thyroid; 2004 Jul; 14(7):510-20. PubMed ID: 15307940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and laboratory aspects of thyroid autoantibodies.
    Sinclair D
    Ann Clin Biochem; 2006 May; 43(Pt 3):173-83. PubMed ID: 16704751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Clinical Value and Variation of Antithyroid Antibodies during Pregnancy.
    Li C; Zhou J; Huang Z; Pan X; Leung W; Chen L; Zhang Y; Wang L; Sima Y; Gober HJ; Zhang N; Qiu X; Li L; Guan L; Wang L
    Dis Markers; 2020; 2020():8871951. PubMed ID: 33144894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.
    Manns MP; Rambusch EG
    J Hepatol; 1999; 31 Suppl 1():39-42. PubMed ID: 10622558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-lymphocytes in autoimmune thyroid diseases (AITD).
    Volpé R
    Rev Endocr Metab Disord; 2000 Jan; 1(1-2):79-86. PubMed ID: 11704995
    [No Abstract]   [Full Text] [Related]  

  • 32. The antibody response in human autoimmune thyroid disease.
    McIntosh RS; Asghar MS; Weetman AP
    Clin Sci (Lond); 1997 Jun; 92(6):529-41. PubMed ID: 9205412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders.
    Yang DH; Ho LJ; Lai JH
    World J Gastroenterol; 2014 Mar; 20(11):2962-70. PubMed ID: 24659887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV and autoimmunity.
    Ferri S; Muratori L; Lenzi M; Granito A; Bianchi FB; Vergani D
    Curr Pharm Des; 2008; 14(17):1678-85. PubMed ID: 18673191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection.
    Fallahi P; Ferrari SM; Politti U; Giuggioli D; Ferri C; Antonelli A
    Int J Endocrinol; 2014; 2014():935131. PubMed ID: 25374602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders.
    Fallahi P; Ferrari SM; Vita R; Benvenga S; Antonelli A
    Rev Endocr Metab Disord; 2016 Dec; 17(4):529-535. PubMed ID: 27220938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune hepatitis versus viral hepatitis C.
    Strassburg CP; Manns MP
    Liver; 1995 Oct; 15(5):225-32. PubMed ID: 8531590
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.